Ipca Labs Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for IPCA LABS LTD, and what generic and branded alternatives to IPCA LABS LTD drugs are available?
IPCA LABS LTD has twenty-nine approved drugs.
Summary for Ipca Labs Ltd
| US Patents: | 0 |
| Tradenames: | 26 |
| Ingredients: | 25 |
| NDAs: | 29 |
Drugs and US Patents for Ipca Labs Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ipca Labs Ltd | ALENDRONATE SODIUM | alendronate sodium | TABLET;ORAL | 206387-002 | Jun 4, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ipca Labs Ltd | WARFARIN SODIUM | warfarin sodium | TABLET;ORAL | 200104-001 | Jun 27, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ipca Labs Ltd | LOSARTAN POTASSIUM | losartan potassium | TABLET;ORAL | 200290-002 | Aug 30, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ipca Labs Ltd | LOSARTAN POTASSIUM | losartan potassium | TABLET;ORAL | 200290-001 | Aug 30, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ipca Labs Ltd | METOPROLOL TARTRATE | metoprolol tartrate | TABLET;ORAL | 078459-002 | Jun 17, 2008 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ipca Labs Ltd | ALENDRONATE SODIUM | alendronate sodium | TABLET;ORAL | 206387-001 | Jun 4, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
